Structural characterization of M8C10, a neutralizing antibody targeting a highly conserved prefusion-specific epitope on the metapneumovirus fusion trimerization interface
Journal of Virology · 2023
DOI: 10.1128/jvi.01052-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2023. Verfasst von Xiao Xiao und 15 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases and Vaccines Discovery, Merck & Co., Inc., West Point, Pennsylvania, USA. Hauptthemen laut MEDLINE: Metapneumovirus, Paramyxoviridae Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Merck (Merck & Co.).
Abstract (Originalsprache)
Human metapneumovirus (hMPV) is a major respiratory pathogen worldwide. Here, we report the crystal structure of a neutralizing antibody M8C10 isolated from human B cells that targets the viral fusion protein (hMPV-F) trimerization interface. This is a novel prefusion-specific epitope that is highly conserved across hMPV strains and other related viruses. The interactions between M8C10 and hMPV-F are largely driven by residues on the light chain with most hypermutated light chain residues on or near the interface. This highlights the immune recognition of a buried trimerization interface during the in vivo affinity maturation process. In addition, in vivo cotton rat challenge studies were performed that show M8C10 provides strong lung protection against hMPV A viral challenge. The hMPV-F:M8C10 Fab structure reported reveals a class of hMPV antibodies in the human immune repertoire with a novel neutralization mechanism, targeting the trimerization interface of hMPV-F antigen. IMPORTANCE Human metapneumovirus (hMPV) is a common pathogen causing lower respiratory tract infections worldwide and can develop severe symptoms in high-risk populations such as infants, the elderly, and immunocompromised patients. There are no approved hMPV vaccines or neutralizing antibodies available for therapeutic or prophylactic use. The trimeric hMPV fusion F protein is the major target of neutralizing antibodies in human sera. Understanding the immune recognition of antibodies to hMPV-F antigen will provide critical insights into developing efficacious hMPV monoclonal antibodies and vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases and Vaccines Discovery, Merck & Co., Inc., West Point, Pennsylvania, USA.
- Discovery Biologics, Merck & Co., Inc., Boston, Massachusetts, USA.
- MRL Postdoctoral Research Program, Merck & Co., Inc., Kenilworth, New Jersey, USA.
- Protein and Structural Chemistry, Merck & Co., Inc., West Point, Pennsylvania, USA.
- Quantitative Biosciences, Merck & Co., Inc., West Point, Pennsylvania, USA.
- Data Science and Scientific Informatics, Merck & Co., Inc., Rahway, New Jersey, USA.
ORCID-Profile: Michael J Eddins
Förderung
- Merck (Merck & Co.)
Zitieren
APA
Xiao, X., Wen, Z., Chen, Q., Shipman, J. M., Kostas, J., Reid, J. C., Warren, C., Tang, A., Luo, B., O'Donnell, G., Fridman, A., Chen, Z., Vora, K. A., Zhang, L., Su, H. P., & Eddins, M. J. (2023). Structural characterization of M8C10, a neutralizing antibody targeting a highly conserved prefusion-specific epitope on the metapneumovirus fusion trimerization interface. Journal of Virology. https://doi.org/10.1128/jvi.01052-23
Vancouver
Xiao X, Wen Z, Chen Q, Shipman JM, Kostas J, Reid JC, et al. Structural characterization of M8C10, a neutralizing antibody targeting a highly conserved prefusion-specific epitope on the metapneumovirus fusion trimerization interface. Journal of Virology. 2023. doi:10.1128/jvi.01052-23
BibTeX
@article{Xiao2023,
author = {Xiao, Xiao and Wen, Zhiyun and Chen, Qing and Shipman, Jennifer M and Kostas, James and Reid, John C and Warren, Christopher and Tang, Aimin and Luo, Bin and O'Donnell, Gregory and Fridman, Arthur and Chen, Zhifeng and Vora, Kalpit A and Zhang, Lan and Su, Hua-Poo and Eddins, Michael J},
title = {Structural characterization of M8C10, a neutralizing antibody targeting a highly conserved prefusion-specific epitope on the metapneumovirus fusion trimerization interface},
journal = {Journal of Virology},
year = {2023},
doi = {10.1128/jvi.01052-23}
}
EUVIMED